Synthesis, molecular docking and ADMET prediction of novel swertiamarin analogues for the restoration of type-2 diabetes: an enzyme inhibition assay.
Swertiamarin is a lead, biologically active compound obtained from Enicostemma littorale Blume and known to be identified for the anti-diabetic activity. Present work comprises the synthesis and structural optimization of seven novel swertiamarin analogues and those were not being reported elsewhere...
| Published in: | Natural Product Research Vol. 36; no. 9; pp. 2197 - 2208 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Journal Article |
| Published: |
Taylor & Francis Ltd
May2022
|
| Online Access: | View this record in EBSCOhost |